Key facts
- Notable investors include Goldport Capital, Shanghai Zhangjiang Science & Technology Venture Capital, Tailong VC, Shicui Capital, Tahoe Venture — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Phigine Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Phigine Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Phigine Medical
Manufacturer of cardiovascular circulatory auxiliary products designed for cardiovascular treatment. The company focuses on the research, development, and industrialization of cardiovascular circulatory auxiliary products and related auxiliary devices, to help restore cardiac function, stabilize cardiovascular hemodynamics, and treat cardiac pump dysfunction through circulatory support, enabling advanced cardiovascular treatment for patients.
- Sector
- Healthcare
- HQ
- Jiaxing, China
- Founded
- 2023
- Ownership
- Privately Held (backing)
Phigine Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Phigine Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Phigine Medical in its N-PORT filings yet. We sweep new filings monthly.